Literature DB >> 6343627

Expression of a transformation-related protein (p53) in the malignant stage of Friend virus-induced diseases.

S K Ruscetti, E M Scolnick.   

Abstract

Stage 1 (pre-malignant) and stage 2 (malignant) cells derived from mice infected with Friend murine leukemia virus or polycythemia-inducing Friend virus complex were examined and compared for the expression of a transformation-related cellular protein, p53. Stage 2 cells were found to express high levels of p53, whereas stage 1 cells did not express detectable levels of this protein. These results indicate that p53 may be a marker for transformed cells present in the second stage of diseases induced by Friend murine leukemia virus or polycythemia-inducing Friend virus complex.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6343627      PMCID： PMC256578     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  27 in total

1.  Clonal analysis of the late stages of erythroleukemia induced by two distinct strains of Friend leukemia virus.

Authors:  D Mager; M E MacDonald; I B Robson; T W Mak; A Bernstein
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

3.  Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.

Authors:  C Friend; W Scher; J G Holland; T Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

4.  A common transformation-related protein in murine sarcomas and leukemias.

Authors:  G Jay; A B DeLeo; E Appella; G C Dubois; L W Law; G Khoury; L J Old
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

5.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

6.  Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells.

Authors:  F McCormick; E Harlow
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

7.  Emergence of tumorigenic cells during the course of Friend virus leukemias.

Authors:  F Wendling; F Moreau-Gachelin; P Tambourin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

8.  Increased concentration of an apparently identical cellular protein in cells transformed by either Abelson murine leukemia virus or other transforming agents.

Authors:  V Rotter; M A Boss; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

9.  Friend disease in vitro.

Authors:  T M Dexter; T D Allen; N G Testa; E Scolnick
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice.

Authors:  H A Freedman; F Lilly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307
View more
  16 in total

1.  Characterization of the human p53 gene promoter.

Authors:  S P Tuck; L Crawford
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

2.  Cell cycle dependent genes inducible by different mitogens in cells from different species.

Authors:  C W Gibson; S R Rittling; R R Hirschhorn; L Kaczmarek; B Calabretta; C D Stiles; R Baserga
Journal:  Mol Cell Biochem       Date:  1986-06       Impact factor: 3.396

3.  Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation.

Authors:  B Rovinski; D Munroe; J Peacock; M Mowat; A Bernstein; S Benchimol
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

4.  Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines.

Authors:  P W Hinds; C A Finlay; A B Frey; A J Levine
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

5.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.

Authors:  C A Finlay; P W Hinds; T H Tan; D Eliyahu; M Oren; A J Levine
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

6.  Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells.

Authors:  H W Stürzbecher; C Addison; J R Jenkins
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

7.  Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division.

Authors:  D W Shen; F X Real; A B DeLeo; L J Old; P A Marks; R A Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  Energy requirement for degradation of tumor-associated protein p53.

Authors:  R M Gronostajski; A L Goldberg; A B Pardee
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

9.  Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70.

Authors:  T Soussi; C Caron de Fromentel; H W Stürzbecher; S Ullrich; J Jenkins; P May
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.

Authors:  P K Liu; E Kraus; T A Wu; L C Strong; M A Tainsky
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.